Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F. Meillan N, et al. Among authors: doyen j. Radiother Oncol. 2021 Aug;161:198-204. doi: 10.1016/j.radonc.2021.06.006. Epub 2021 Jun 16. Radiother Oncol. 2021. PMID: 34144078
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.
Azria D, Doyen J, Jarlier M, Martel-Lafay I, Hennequin C, Etienne P, Vendrely V, François E, de La Roche G, Bouché O, Mirabel X, Denis B, Mineur L, Berdah J, Mahé M, Bécouarn Y, Dupuis O, Lledo G, Seitz J, Bedenne L, Gourgou-Bourgade S, Juzyna B, Conroy T, Gérard J. Azria D, et al. Among authors: doyen j. Ann Oncol. 2017 Oct 1;28(10):2436-2442. doi: 10.1093/annonc/mdx351. Ann Oncol. 2017. PMID: 28961836 Free article. Clinical Trial.
Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
Kinj R, Doyen J, Hannoun-Lévi JM, Naghavi AO, Chand ME, Baudin G, Ferrero JM, François E, Evesque L, Borchiellini D, Benezery K, Bondiau PY. Kinj R, et al. Among authors: doyen j. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e15-e21. doi: 10.1016/j.clon.2020.06.009. Epub 2020 Jul 5. Clin Oncol (R Coll Radiol). 2021. PMID: 32641243 Free article.
Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: A French retrospective study.
Dalmasso C, Alapetite C, Bolle S, Goudjil F, Lusque A, Desrousseaux J, Claude L, Doyen J, Bernier-Chastagner V, Ducassou A, Sevely A, Roques M, Tensaouti F, Laprie A. Dalmasso C, et al. Among authors: doyen j. Radiother Oncol. 2024 May;194:110157. doi: 10.1016/j.radonc.2024.110157. Epub 2024 Feb 16. Radiother Oncol. 2024. PMID: 38367939
Prognostic factors in 1,038 women with metastatic breast cancer.
Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E. Largillier R, et al. Among authors: doyen j. Ann Oncol. 2008 Dec;19(12):2012-9. doi: 10.1093/annonc/mdn424. Epub 2008 Jul 17. Ann Oncol. 2008. PMID: 18641006 Free PMC article.
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.
Gérard JP, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, Chapet O, Romestaing P. Gérard JP, et al. Among authors: doyen j. Cancer Radiother. 2012 Dec;16(8):688-96. doi: 10.1016/j.canrad.2012.09.003. Epub 2012 Nov 13. Cancer Radiother. 2012. PMID: 23153504
Aims of combined modality therapy in rectal cancer (M0).
Gerard JP, Benezery K, Doyen J, Francois E. Gerard JP, et al. Among authors: doyen j. Recent Results Cancer Res. 2014;203:153-69. doi: 10.1007/978-3-319-08060-4_11. Recent Results Cancer Res. 2014. PMID: 25103004 Review.
136 results